HOME >> MEDICINE >> NEWS
Study finds HIV protease inhibitor drugs may adversely affect the scaffolding of the cell nucleus

UCLA scientists, along with collaborators from Purdue University, have demonstrated that HIV protease inhibitors crucial drugs for HIV treatment block a cellular enzyme important for generating the structural scaffolding for the cell nucleus.

Published in the July 16 early edition of Proceedings of the National Academy of Sciences, these biochemical findings may offer insights into the side effects of HIV protease inhibitors, including metabolic syndrome and regional losses of some of the bodys fat tissue. These side effects occur in up to one-third of patients taking anti-HIV drug regimens.

We show, for the first time, that certain HIV protease inhibitor drugs directly inhibit an enzyme called ZMPSTE24, which is important for generating the structural scaffolding supporting the cell nucleus, said Catherine Coffinier, Ph.D., study author and an assistant researcher at the David Geffen School of Medicine at UCLA.

UCLA researchers added HIV protease inhibitors to cultures of mouse and human fibroblast cells. They found that the inhibition of ZMPSTE24 by the HIV protease inhibitor drugs led to an accumulation of prelamin A, which is a precursor to mature lamin A a key molecule in the structural scaffolding for the cell nucleus. ZMPSTE24 is a membrane-bound intracellular zinc metalloproteinase that is required for the conversion of prelamin A to mature lamin A.

Interestingly, researchers found that the accumulation of prelamin A was exaggerated in cells that contained half the normal amount of ZMPSTE24.

Genetic defects in ZMPSTE24 in humans lead to an accumulation of prelamin A and cause a host of disease phenotypes, including partial loss of body fat depots and metabolic syndrome.

The fact that HIV protease inhibitors block ZMPSTE24 and have been associated with side effects similar to those observed with a genetic deficiency in ZMPSTE24 is intriguing, said Loren Fong, Ph.D., study author and an associa
'"/>

Contact: Rachel Champeau
rchampeau@mednet.ucla.edu
310-794-0777
University of California - Los Angeles
16-Jul-2007


Page: 1 2

Related medicine news :

1. Study, meta-analysis examine factors associated with death from heatstroke
2. Study says COPD testing is not measuring up
3. Study suggests loss of 2 types of neurons -- not just 1 -- triggers Parkinsons symptoms
4. Study reveals gaps in vaccine financing for underinsured children
5. Study suggests nonpharmaceutical interventions may be helpful in severe influenza outbreaks
6. Study shows radiofrequency ablation highly effective in treating kidney tumors
7. Study says normal but out-of-control enzyme may be culprit that signals some cells to become cancer
8. Study outlines how stroke, head injury can increase risk of Alzheimers disease
9. Study identifies new regulator of fat metabolism
10. Study shows Diachrome improves blood sugar control in people with type 2 diabetes
11. Study examines characteristics of female high school students who report steroid use

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:6/19/2019)... NEW ORLEANS (PRWEB) , ... June 19, 2019 , ... ... using mothers in the United States, has filed class action lawsuits in 34 ... Named as defendants in the class actions are an array of pharmaceutical manufacturers, distributors ...
(Date:6/18/2019)... ... , ... EMulate Therapeutics, Inc. , a clinical-stage therapeutic ... has received notice that the US Food and Drug Administration (FDA) accepted for ... Pediatric system. The FDA granted the Humanitarian Use Device (HUD) designation for ...
(Date:6/16/2019)... NEWPORT BEACH, Calif. (PRWEB) , ... June 14, ... ... Data Protection / Cyber Security solutions, today announced it has received the ... showcasing the award winning DLP that Works Platform along with the latest additions ...
(Date:6/14/2019)... ... 2019 , ... Docs is proud to present the following recently reviewed and approved providers for May 2019. , FL ... , BREAST SURGERY, Dr. Debbie Berlin , CARDIOLOGY, ... Dr. Christopher J. Pastore , Dr. Yamilet Tirado , DERMATOLOGY, ...
(Date:6/13/2019)... ... June 13, 2019 , ... ... Second Test (BL30SEC) has been accepted by the 2019 National Conference of Interstate ... N requirements. , The Charm BL30SEC test was validated by third party ...
Breaking Medicine News(10 mins):
(Date:6/13/2019)... ... June 13, 2019 , ... Recent lawsuits, including Hyatt ... back problem, underscore the responsibility of employers to provide reasonable accommodations to their ... are reasonable and which are not - from requests by hearing-impaired and disabled ...
(Date:6/13/2019)... ATLANTA (PRWEB) , ... June 13, 2019 , ... ... is celebrating 10 years of educating medical professionals and the public about non-invasive ... PBM this fall in Orlando, Florida to help commemorate the milestone. ...
(Date:6/13/2019)... ... June 13, 2019 , ... HMP, a leading healthcare education and events company, ... “Top 25 Fastest-Growing Shows in Net Square Footage” by Trade Show News Network (TSNN). ... growth over that period. Winners will be honored during the 2019 TSNN Awards, taking ...
Breaking Medicine Technology:
Cached News: